Patrys Limited Stock Price

ASX:PAB Community·AU$13.1m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

PAB Share Price Performance

AU$0.043

0.01 (19.49%)

AU$0.043

0.01 (19.49%)

AU$0.043

Sat, 1 Nov 25

Share PriceAU$0.043

PAB Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks

1 Reward

View Full Analysis

Patrys Limited Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -0.0099
: 100.00%
: -363.69%
: 0%

View Full Analysis

About PAB

Founded: 2006
Employees: n/a
CEO: n/a
WebsiteView website: patrys.com

Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Melbourne, Australia.